Clinical Trials Search Results

This is a Phase 2, double-blind, parallel-group, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of multiple doses of ONO-2808 in patients with MSA. This is the first study of ONO-2808 in patients with MSA.

In this study, researchers will learn more about a study drug called BIIB122 in participants with early-stage Parkinson's disease (PD).

The primary purpose of this study is to demonstrate the superiority of UCB0022 as an adjunctive treatment to stable dose of standard-of-care (SoC) (including at least levodopa therapy) over placebo with regard to motor fluctuations time spent in the OFF state (OFF time) in study participants with advanced Parkinson's Disease (PD).

This study will evaluate the safety, biomarkers, and efficacy of tominersen compared with placebo in participants with prodromal and early manifest Huntington's Disease.

Learn about the ACTIV-2 clinical trial for outpatients with COVID-19.

Learn about the Adaptive COVID-19 Treatment Trial 4 (ACTT-4) for patients with COVID-19.

Learn about the ANX005-HD-01 clinical trial for patients with Huntington's disease or at risk for Huntington's Disease.

Learn about the ATH-1017-AD-0202 clinical trial for patients who have been diagnosed with mild to moderate Alzheimer's disease.

Learn about the Boca Biolistics clinical trial for patients with acute or chronic tropical or infectious diseases.